CFGS
MIST icon

Concourse Financial Group Securities’s Milestone Pharmaceuticals MIST Stock Holding History

Concourse Financial Group Securities’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-245
Closed -$1.47K – 2442
2021
Q3 		$1K Hold
245
– – ﹤0.01% 2331
2021
Q2 		$1K Hold
245
– – ﹤0.01% 2297
2021
Q1 		$1K Hold
245
– – ﹤0.01% 2262
2020
Q4 		$2K Hold
245
– – ﹤0.01% 2101
2020
Q3 		$2K Hold
245
– – ﹤0.01% 2009
2020
Q2 		$1K Hold
245
– – ﹤0.01% 2015
2020
Q1 		$0 Hold
245
– – ﹤0.01% 2250
2019
Q4 		$4K Buy
+245
New +$4.33K ﹤0.01% 1693

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Concourse Financial Group Securities's MIST Position: Q4 2021 in Review

Concourse Financial Group Securities sold out of Milestone Pharmaceuticals (MIST) in Q4 2021, closing a stake of 245 shares — an estimated $1.47K sold.

Concourse Financial Group Securities first reported a position in MIST in Q4 2019 and held it in 8 quarters. The position peaked at $4K in Q4 2019. 28 funds tracked by Wall St. Rank hold MIST as of Q4 2021.

  • Concourse Financial Group Securities reported no remaining Milestone Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 245 Milestone Pharmaceuticals shares in Q4 2021, an estimated $1.47K.
  • Concourse Financial Group Securities first reported a position in Milestone Pharmaceuticals in Q4 2019 and held it in 8 quarters.
  • Concourse Financial Group Securities's Milestone Pharmaceuticals position peaked at $4K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2021.

Based on Concourse Financial Group Securities's 13F filing for Q4 2021, filed 7 Feb 2022.